Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 199 | 6,634 | 9,163 | 7,999 | 8,727 |
| Cost of Goods | N/A | 633 | 728 | 568 | 774 |
| Gross Profit | 199 | 6,001 | 8,435 | 7,431 | 7,953 |
| Operating Expenses | 7,657 | -80,041 | 73,742 | 70,437 | 55,944 |
| Operating Income | -7,458 | 86,675 | -64,579 | -62,438 | -47,217 |
| Interest Expense | 170 | 4,118 | 5,125 | 5,131 | 5,191 |
| Other Income | 2,133 | 46 | 633 | 958 | 1,270 |
| Pre-tax Income | -5,495 | 82,603 | -69,071 | -66,611 | -51,138 |
| Net Income Continuous | -5,495 | 82,603 | -69,071 | -66,611 | -51,138 |
| Net Income | $-5,495 | $82,603 | $-69,071 | $-66,611 | $-51,138 |
| EPS Basic Total Ops | -0.02 | 0.77 | -0.65 | -0.63 | -0.47 |
| EPS Basic Continuous Ops | -0.03 | 0.77 | -0.65 | -0.63 | -0.48 |
| EPS Diluted Total Ops | 0.04 | 0.71 | -0.65 | -0.63 | -0.36 |
| EPS Diluted Continuous Ops | 0.04 | 0.70 | -0.65 | -0.63 | -0.40 |
| EBITDA(a) | $-7,096 | $87,728 | $-63,315 | $-61,170 | $-74,542 |